To advance the development of KeraStat® Cream as a treatment of Cutaneous Radiation Injury (CRI). 2
ID: 75A50122C00017 • Type: Award Notice
Overview
Awardee
Award ID
Reported Award
$4,471,066
Award Date
March 17, 2022
Posted
March 23, 2022, 5:05 p.m. EDT
Set Aside
None
NAICS
None
PSC
None
Place of Performance
Winston Salem, NC 27101
United States
Source
Pricing
Cost Plus Fixed Fee
To advance the development of KeraStat® Cream as a treatment of Cutaneous Radiation Injury (CRI). (75A50122C00017) was awarded to Keranetics on 3/23/22 by HHS Office of the Assistant Secretary for Preparedness and Response.
Documents
Posted documents for Award Notice 75A50122C00017
Question & Answer
Opportunity Lifecycle
Procurement notices related to Award Notice 75A50122C00017
Award Notifications
Agency published notification of awards for Award Notice 75A50122C00017
Contract Awards
Prime contracts awarded through Award Notice 75A50122C00017
Similar Active Opportunities
Open contract opportunities similar to Award Notice 75A50122C00017
Additional Details
Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > ASPR BARDA DIV CONTRACTS MGMT & ACQ
FPDS Organization Code
7505-75ANBA
Source Organization Code
500155218
Last Updated
April 15, 2022
Last Updated By
james.bowers@hhs.gov
Archive Date
April 15, 2022